How Immunify.Life Initiatives are Transforming Public Health -Breaking
[ad_1]
Health Initiatives that Improve Immunity.Hundreds of millions of people in the developing world live without access to essential medical information because there is no medical infrastructure. This infrastructure is essential for patients, physicians, and governments to make informed public health decisions. Immunify.Life is aiming to create a healthy ecosystem for health powered by AI (artificial intelligence) and secured with blockchain technology.
The system stores health information in an AI-assisted, digital registry. But, Immunity.Life is not a centralized platform. It lives on blockchain. Immunity.Life’s foundation is based on this distributed network. It provides secure, transparent access to interoperable, consistent data.
It is free and allows professionals to integrate their needs by collecting, storing, and transmitting data about health using smartphones or computers. It allows remote medical supervision as well as real-time accessibility to vital information professionals and patients require. Immunify.Life can be used to create an ecosystem of self-sustaining, transformative change that encourages sustainability.
All patients in emerging countries and around the world will benefit from this ecosystem. Immunify.Life is an integrated platform that aims to create a healthier health system. It can directly support specific outcomes and positively impact health behaviors. Immunify.Life allows for countless collaborations by leveraging AI technology and blockchain technology to access Big Data. The partners could be governments, hospitals, sponsoring entities, donors, and non-profit organizations.
Immunify.Life has been participating in these strategic partnerships since today, including those with the Masinde Muliro University of Science and Technology MMUST and State of the Heart Recovery Centre SHRC.
Immunify.Life & Masinde Muliro University of Science and Technology (MMUST)
With approval from the Institutional Ethics Committee and National Commission for Science, Technology & Innovation (NACOSTI), Masinde Muliro University of Science and Technology (MMUST), and Immunify.Life have entered into a 5-year collaboration agreement. The two organizations will collaborate in Kenya to conduct clinical research that improves patient outcomes and public health. Their first major project will explore incentive effectiveness and paperless tracking for HIV treatment adherence and outcomes in Kenya’s low socio-economic communities.
An estimated 1.5 million Kenyans are living with HIV, and 4.5% of adults (15 to 49) have the disease. The project aims at improving our understanding of the 42,000 new infections every year. Its streamlined application will make it possible to use the Immunify.Life platform as a tool for capturing vital data on these populations.
This innovative study will be a part of the Strategic Direction on HIV in Kenya and help improve HIV health outcomes. Immunify.Heath along with MMUST and MMUST will use referral tracking systems, better access to human resources distributed, advocacy for anti retrotreatment (ART) and adherence interventions that improve care quality and outcomes.
Immunify.Life & State of the Heart Recovery Centre (SHRC)
Immunify.Life is also a partner with the State of the Heart Recover Centre in Albuquerque (New Mexico). Around 500,000 people each year die from illicit and medical drug use, according to the World Health Organization. Overdose is responsible for more than 30% and 70% respectively of the deaths. SHRC will use data and technological solutions for addiction recovery and treatment to better understand the figures. This partnership, which will focus on the opioid addiction problem in particular, will investigate the potential and difficulties of drug abuse.
SHRC offers all-inclusive addiction treatment, which includes opioid addiction. SHRC has been accredited as a treatment center for opioid addiction. However, the facility adheres to an holistic approach that focuses on emotional, spiritual and physical recovery. The facility combines evidence-based treatment methods with mobile devices that provide biometric feedback to deliver the program.
The Immunify.Life platform is a mobile-native integration that seamlessly integrates with existing programs. So, Immunity.Life will be able to track, analyze, and report on clinical outcomes, as well behaviour modification related treatment adherence. To encourage patients to follow treatment, the collaboration will integrate IMM tokens. In Q4 2021, a clinical trial of Immunify technology will be conducted in the therapeutic environment.
[ad_2]